Healthcare Triangle signs LOI to acquire Roboticom robotics assets for up to USD 30 million
HCTI•Deal terms and financial context
Consideration is set at up to USD 30 million in cash and equity, to be paid over time.
Roboticom generated about USD 14.1 million in revenue and USD 6.9 million in gross margin in fiscal 2025, and was EBITDA-positive.
Roboticom management projections target USD 153.5 million in revenue and USD 64 million in adjusted operating contribution by fiscal 2029/30.
LOI for Roboticom robotics assets
Healthcare Triangle said it signed a non-binding letter of intent to acquire Roboticom industrial precision robotics automation assets from Crestpoint Capital.
The deal targets customer contracts, intellectual property, trademarks, and business assets tied to Roboticom’s SandRob, ORTIS, and ScultoRob lines.
